Read More Pharma Industry News Yumanity secures $500m worth deal with Merck to develop therapies for neurodegenerative disorders Massachusetts-based Yumanity Therapeutics has secured a drug development deal worth up to nearly $500 million with pharma giant… bypharmanewsdailyJune 27, 2020